What is West Pharmaceutical Services Pre-Tax Income?
Pretax income is the income that a company earns before paying income taxes. West Pharmaceutical Services's pretax income for the
three
months ended in Mar. 2025 was €102 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2025 was €527 Mil.
West Pharmaceutical Services's pretax margin was 15.83%.
During the past 13 years, West Pharmaceutical Services's highest Pretax Margin was 26.45%. The lowest was 8.29%. And the median was 17.28%.
West Pharmaceutical Services Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of West Pharmaceutical Services's Pre-Tax Income
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €527 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (STU:WPS) Pre-Tax Income Explanation
West Pharmaceutical Services's Pretax Margin for the quarter that ended in Mar. 2025 is calculated as
During the past 13 years, West Pharmaceutical Services's highest Pretax Margin was 26.45%. The lowest was 8.29%. And the median was 17.28%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
STU:WPS has been successfully added to your 